Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Inflammatory and Antioxidant Status in Pulmonary Sarcoidosis, Idiopathic Pulmonary Fibrosis and COPD: a Potential Role for Antioxidants

NCT00512967 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT00512967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00512967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Inflammatory and Antioxidant Status in Pulmonary Sarcoidosis, Idiopathic Pulmonary Fibrosis and COPD: a Potential Role for Antioxidants
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Completed
Start date
September 30, 2005
Completion date
June 30, 2006
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd, idiopathic pulmonary fibrosis, interstitial lung diseases, sarcoidosis